Search Results - Ying C

Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation by Yu W, Ji J, Xiao T, Ying C, Fang J, Shen P, Xiao Y

Connect to this object online.

In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor by Heather Zhang, Ying C. Ou, Dan Su, Fan Wang, Lai Wang, Srikumar Sahasranaman, Zhiyu Tang

Connect to this object online.

Comprehensive PBPK model to predict drug interaction potential of Zanubrutinib as a victim or perpetrator by Kun Wang, Xueting Yao, Miao Zhang, Dongyang Liu, Yuying Gao, Srikumar Sahasranaman, Ying C. Ou

Connect to this object online.

Population Pharmacokinetic Analysis of the BTK Inhibitor Zanubrutinib in Healthy Volunteers and Patients With B‐Cell Malignancies by Ying C. Ou, Lucy Liu, Bilal Tariq, Kun Wang, Ashutosh Jindal, Zhiyu Tang, Yuying Gao, Srikumar Sahasranaman

Connect to this object online.

No QTc Prolongation With Zanubrutinib: Results of Concentration‐QTc Analysis From a Thorough QT Study in Healthy Subjects by Song Mu, Borje Darpo, Zhiyu Tang, William Novotny, Manal Tawashi, Hongqi Xue, Michael Willett, Leo Lin, Sri Sahasranaman, Ying C. Ou

Connect to this object online.

Water and sewage systems, socio-demographics, and duration of residence associated with endemic intestinal infectious diseases: A cohort study by MacNab Ying C, Koehoorn Mieke, Chu Rong, Atwater Jim, Shen Hui, Bellack Neil, Teschke Kay, Schreier Hans, Isaac-Renton Judith L

Connect to this object online.

Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation by Dai Y, Chang W, Zhou X, Yu W, Huang C, Chen Y, Ma X, Lu H, Ji R, Ying C, Wang P, Liu Z, Yuan Q, Xiao Y

Connect to this object online.